Futures and Options Trading Platforms

MetaTrader5 (Mac Compatible web version)

DeCarley clients can connect their live futures trading accounts to the MetaTrader 5 platform via a CQG connection.


This platform does not support option trading, but MT5 offers a plethora of tools for comprehensive price analysis, the use of algorithmic trading applications (trading robots, Expert Advisor), and copy trading.

The MT5 platform represents the all-in-one concept and offers impressive analytical tools. The 21 timeframes available enable a comprehensive detailed analysis of all minor price movements. More than 80 technical indicators and analytical tools, including graphic objects, provide detailed analysis of quote dynamics.

 MT5 Futures Trading Platform with CQG connection

Furthermore, the analytical resources of the terminal are not limited to the built-in tools. Traders are welcome to choose between thousands of free-of-charge indicators from the Code Base, purchase or rent applications from the Market of more than 2500 ready-made algorithmic applications, as well as to order custom indicators from professional programmers through the Freelance service. With the high performance of the MQL5 programming language, you can create your own indicator with your own unique characteristics. All these features enhance the analytical capacity of your platform and your ability to achieve the most detailed and accurate technical analysis of quotes.

Futures Trading Mobile App

Full-fledged financial market trading can be enjoyed without even a desktop computer. The only thing you need to do is to install the mobile version of MetaTrader 5 for Android or iOS on your smartphone or tablet. Mobile applications support the full set of trading functions, provide extensive analytical capabilities through the use of technical indicators and graphical objects, as well as allow you to monitor account status, view your trading history, and more.

That's it! Financial markets are at your fingertips with the MetaTrader 5 mobile platform!



Newsletter Trial